Inventor · name-matched record
TABUTEAU HERRIOT
8 granted patents·15 pending applications·6 citations·filing 2024–2025
80Inventor score
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
23 records- 0199US12564587B2Bupropion dosage forms with reduced food and alcohol dosing effectsANTECIP BIOVENTURES II LLC·Filed 2025·Granted Mar 3, 2026·2 cites·21 claims
- 0299US12551489B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Granted Feb 17, 2026·1 cites·23 claims
- 0399US12551488B2Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Granted Feb 17, 2026·1 cites·23 claims
- 0499US12544345B2Compounds and combinations thereof for treating neurological and psychiatric conditionsANTECIP BIOVENTURES II LLC·Filed 2025·Granted Feb 10, 2026·2 cites·23 claims
- 0593US2026041691A1Use of reboxetine to treat narcolepsyAXSOME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0692US2026048129A1Pharmaceutical compositions comprising bupropion and cysteineAXSOME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0789US2026014163A1Use of reboxetine to treat fibromyalgiaAXSOME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0885US2026053758A1Compounds and combinations thereof for treating neurological and psychiatric conditionsANTECIP BIOVENTURES II LLC·Filed 2025·Application pending·0 cites
- 0985US2026069603A1Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1084US2026000677A1Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1183US2026097006A1Compounds and combinations thereof for treating neurological and psychiatric conditionsANTECIP BIOVENTURES II LLC·Filed 2025·Application pending·0 cites
- 1283US2026027127A1Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1382US2026060976A1Compounds and combinations thereof for treating neurological and psychiatric conditionsANTECIP BIOVENTURES II LLC·Filed 2025·Application pending·0 cites
- 1480US2026041651A1Bupropion and dextromethorphan for reduction of suicide risk in depression patientsANTECIP BIOVENTURES II LLC·Filed 2025·Application pending·0 cites
- 1578US12576078B1Compounds and combinations thereof for treating neurological and psychiatric conditionsANTECIP BIOVENTURES II LLC·Filed 2025·Granted Mar 17, 2026·0 cites·18 claims
- 1678US2026097040A1Use of reboxetine to treat narcolepsyAXSOME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1778US2026077048A1Pharmaceutical compositions comprising meloxicamAXSOME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1876US2026007655A1Compounds and combinations thereof for treating neurological and psychiatric conditionsANTECIP BIOVENTURES II LLC·Filed 2025·Application pending·0 cites
- 1971US12569479B2Bupropion as a modulator of drug activityANTECIP BIOVENTURES II LLC·Filed 2024·Granted Mar 10, 2026·0 cites·21 claims
- 2071US2026014165A1Use of esreboxetine to treat nervous system disorders such as fibromyalgiaAXSOME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2167US12565478B1(S)-2-((S)-(2-ethoxyphenoxy)(phenyl)methyl)-4-nitrosomorpholineAXSOME THERAPEUTICS INC·Filed 2025·Granted Mar 3, 2026·0 cites·22 claims
- 2265US12544383B1Methods of treating migraines with a combination of a meloxicam and a rizatriptanAXSOME THERAPEUTICS INC·Filed 2025·Granted Feb 10, 2026·0 cites·24 claims
- 2360US2026014142A1Dosage forms and methods for enantiomerically enriched or pure bupropionAXSOME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TABUTEAU HERRIOT files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →